LC
VCYT icon

Lindbrook Capital’s Veracyte VCYT Stock Holding History

Lindbrook Capital’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$4.74K Hold
160
– – ﹤0.01% 1977
2024
Q4 		$6.34K Hold
160
– – ﹤0.01% 1878
2024
Q3 		$5.45K Buy
160
+19
+13% +$535 ﹤0.01% 1979
2024
Q2 		$3.06K Buy
141
+25
+22% +$526 ﹤0.01% 2213
2024
Q1 		$2.57K Buy
116
+12
+12% +$293 ﹤0.01% 2153
2023
Q4 		$2.86K Buy
104
+10
+11% +$241 ﹤0.01% 2138
2023
Q3 		$2.1K Sell
94
-28
-23% -$720 ﹤0.01% 2110
2023
Q2 		$3.11K Buy
122
+15
+14% +$364 ﹤0.01% 1989
2023
Q1 		$2.39K Sell
107
-6
-5% -$145 ﹤0.01% 2168
2022
Q4 		$2.68K Buy
+113
New +$2.63K ﹤0.01% 2108
2021
Q2 		– Sell
-220
Closed -$12K – 2006
2021
Q1 		$12K Buy
220
+100
+83% +$5.76K ﹤0.01% 960
2020
Q4 		$6K Buy
+120
New +$5.56K ﹤0.01% 1141

Other funds holding VCYT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Lindbrook Capital's VCYT Position: Q1 2025 in Review

Lindbrook Capital held its Veracyte (VCYT) position steady in Q1 2025 at 160 shares worth $4.74K. The position accounts for ﹤0.01% of the portfolio, ranked #1977.

Lindbrook Capital first reported a position in VCYT in Q4 2020 and has held it in 12 quarters since. The position peaked at $12K in Q1 2021. 287 funds tracked by Wall St. Rank hold VCYT as of Q1 2025.

  • Lindbrook Capital held 160 shares of Veracyte worth $4.74K as of Q1 2025.
  • Lindbrook Capital left its Veracyte share count unchanged in Q1 2025.
  • Veracyte made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1977 holding.
  • Lindbrook Capital first reported a position in Veracyte in Q4 2020 and has held it in 12 quarters since.
  • Lindbrook Capital's Veracyte position peaked at $12K in Q1 2021.
  • 287 funds tracked by Wall St. Rank held Veracyte as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.